Skip to main content
Equibles

ALLIANCEBERNSTEIN L.P.

Position in SPRY — ARS Pharmaceuticals, Inc.

CIK 1109448 NASHVILLE, TN
Back to SPRY Full portfolio

Position in SPRY

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$476,514
+$139,415 QoQ
Shares Held
59,490
+41.7% QoQ
Ownership
0.060%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#78
of 209 holders
Holding Since
Jun 2021
14 quarters on record
Voting authority Sole 93% Shared 0% None 7%

Common Shares in SPRY Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ALLIANCEBERNSTEIN L.P. holds $5,185,395,108 across 257 Biotechnology names. SPRY ranks #168 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,019,315 $1,499,784,339
2 ARGX
Argenx SE
 395,661 $367,082,405
3 GMAB
Genmab A/S
 8,644,877 $237,474,771
4 REGN
Regeneron Pharmaceuticals, Inc.
 292,338 $182,284,436
5 TECH
BIO-TECHNE Corp
 2,002,026 $141,443,136
6 HALO
Halozyme Therapeutics, Inc.
 1,696,538 $132,788,029
7 KYMR
Kymera Therapeutics, Inc.
 981,521 $112,551,013
8 BBIO
BridgeBio Pharma, Inc.
 1,453,504 $108,256,977

All Filings in SPRY

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $476,514 59,490
2026-03-31 $337,099 41,980
2025-12-31 $700,398 60,120
2025-09-30 $26,553,215 2,642,111
2025-06-30 $66,760,087 3,825,793
2025-03-31 $49,348,886 3,922,805
2024-12-31 $40,941,743 3,880,734
2024-09-30 $1,068,070 73,660
2024-06-30 $626,846 73,660
2024-03-31 $604,717 59,170
2023-12-31 $344,089 62,790
2023-09-30 $237,346 62,790
2023-06-30 $166,026 24,780
2021-06-30 $225,497 7,300